Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington DC 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
Amendment No
INARI MEDICAL INC
Name of Issuer
Common Stock 001 par value per share
Title of Class of Securities
45332Y109
CUSIP Number
November 18 2020
Date of Event Which Requires Filing of this Statement
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed
Rule 13d-1b
Rule 13d-1c
Rule 13d-1d
The remainder of this cover page shall be filled out for a reporting persons
initial filing on this form with respect to the subject class of securities and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page
The information required in the remainder of this cover page shall not be deemed
to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934
Act or otherwise subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act however see the Notes
CUSIP No. 45332Y109
Page 2 of 5
1 Names of reporting persons
CVF LLC
2 Check the appropriate box if a member of a group see instructions
a b
3 SEC use only
4 Citizenship or place of organization
Delaware
Number of shares beneficially owned by each reporting person with
5 Sole voting power
2941665
6 Shared voting power
7 Sole dispositive power
2941665
8 Shared dispositive power
9 Aggregate amount beneficially owned by each reporting person
2941665
10 Check if the aggregate amount in Row 9 excludes certain shares see
instructions
11 Percent of class represented by amount in Row 9
6 03
12 Type of reporting person see instructions
OO
CUSIP No. 45332Y109
Page 3 of 5
Item 1
a Name of Issuer
Inari Medical Inc
b Address of Issuers Principal Executive Offices
9 Parker Suite 100 Irvine CA 92618
Item 2
a Names of Person Filing
CVF LLC CVF
b Address of Principal Business Office or if none Residence
222 N LaSalle Street Suite 2000 Chicago Illinois 60601
c Citizenship
Delaware
d Title of Class of Securities
Common Stock 001 par value per share
e CUSIP Number
45332Y109
Item 3 If this statement is filed pursuant to Section 240 13d 1b or 240 13d 2b
or c indicate type of person filing
Not applicable
Item 4 Ownership
a Amount beneficially owned See row 9 of the cover page
b Percent of class See row 11 of the cover page
c Number of shares as to which the person has
i Sole power to vote or direct the vote See row 5 of the cover page
ii Shared power to vote or to direct the vote See row 6 of the cover page
iii Sole power to dispose or to direct the disposition of See row 7 of the
cover page
iv Shared power to dispose or to direct the disposition of See row 8 of the
cover page
CUSIP No 45332Y109
Page 4 of 5
Item 5 Percent of class is based on i the number of shares held by CVF as of
November 18 2020 and ii the number of shares of common stock outstanding as of
November 6 2020 48710821 as reported by the Issuer in its most recent Quarterly
Report on Form 10 Q filed with the Securities and Exchange Commission on
November 12 2020
Ownership of Five Percent or Less of a Class
Not applicable
Item 6 Ownership of More Than Five Percent on Behalf of Another Person
Not applicable
Item 7 Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company or Control Person
Not applicable
Item 8 Identification and Classification of Members of the Group
Not applicable
Item 9 Notice of Dissolution of Group
Not applicable
Item 10 Certifications
By signing below I certify that, to the best of my knowledge and belief the
securities referred to above were not acquired and are not held for the purpose
of or with the effect of changing or influencing the control of the issuer of
the securities and were not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect
CUSIP No 45332Y109
Page 5 of 5
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief I certify
that the information set forth in this statement is true complete and correct
Dated November 20 2020
CVF LLC
By s Richard H Robb
Its Manager